Abiopharma

Natera - I-SPY 2 Publication in Nature Communications ShowsSignatera™ Can Predict Treatment Response and Recurrence Risk in Early-Stage Breast Cancer

NexGelRx Receives Additional Investment from Eric Gruntfest of Diesis Holdings, LLC and Appoints Him as Board Observer and Strategic Advisor

Humacyte Announces Credit Facility of Up to $77.5 Million with Avenue Capital

Zynex Financial Restructuring Puts Company on Path to Long-Term Success

Lipocines PPD Phase 3 Study (LPCN 1154) Hits 80% Enrollment Milestone

Jushi Holdings Inc. Announces Amendment to CEO Employment Agreement

Zimmer Biomet Holdings, Inc. Notification

Integer Holdings Corporation Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights – ITGR

Repligen Introduces Next-Generation Chromatography Resins to Advance New Modality Workflows

Royalty Pharma Acquires Royalty Interest in Nuvalent’s Neladalkib and Zidesamtinib for Up to $315 Million